DUOX2 and neoplasm: The increased levels of angiogenesis could thus have contributed to increased HIF-1 basal levels in the DUOX2 negative tumors and increased drug uptake in both tumor types, especially since cisplatin can be retained in red blood cells for up to two years after treatment [59].